Rp-cAMPS is a membrane-permeable, competitive cAMP antagonist used to block PKA activation by binding to regulatory subunits without dissociating the kinase holoenzyme; it inhibits synaptic plasticity without affecting normal synaptic transmission; it is applied in vitro and in vivo to study cAMP-dependent signaling pathways, particularly in the context of pain and synaptic function in arthritic conditions.